Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong loan portfolio growth, reduction in risk-rated loans, and strategic office loan reduction. Despite some unclear responses in the Q&A, the company demonstrates financial resilience with increased borrowing capacity and focus on resolving high-risk loans. The positive outlook on origination opportunities and strategic capital deployment supports a positive sentiment.
GAAP net loss for full year 2025 $1 million or $0.02 per diluted common share, compared to a distributable earnings loss of $7 million or $0.12 per diluted common share. The reasons for the loss were not explicitly mentioned.
GAAP net loss for Q4 2025 Approximately $4 million or $0.07 per diluted common share. The reasons for the loss were not explicitly mentioned.
Distributable earnings for Q4 2025 Approximately $8 million or $0.15 per diluted common share, including a realized gain of $2 million or $0.04 per diluted common share from the partial sale of the North Carolina office REO property. Excluding this gain, distributable earnings were $6 million or $0.11 per diluted common share.
Loan portfolio growth in Q4 2025 Increased to an outstanding principal balance of $1.6 billion, a 24% increase versus Q3 2025. This growth was driven by closing 8 new loan commitments totaling $393 million.
Reduction in office loans Decreased to $447 million, a 10% reduction quarter-over-quarter and a 30% reduction since year-end 2024. This was achieved through repayments, restructuring, and strategic exits.
Risk rated 4 and 5 loans Reduced by 13% quarter-over-quarter, primarily due to restructuring a $81 million senior risk rated 4 loan into a $65 million senior risk rated 3 loan and an $8 million risk rated 4 subordinated loan. The sponsor repaid part of the principal and committed additional equity.
CECL reserve at year-end 2025 $127 million, representing 8% of the total outstanding principal balance of loans held for investment. This was a $10 million increase from Q3 2025 but an $18 million decrease year-over-year from December 31, 2024. 92% of the reserve relates to risk rated 4 and 5 loans.
Available capital at end of Q4 2025 $110 million. This was supported by increased borrowing capacity of $250 million and reduced borrowing costs through upsizing facilities and redeeming a securitization.
New Loan Commitments: Closed 13 new loan commitments totaling $486 million in the second half of 2025, with over 50% collateralized by residential and industrial properties.
Co-Investment Strategy: More than half of the dollars committed in new loans represented co-investment opportunities alongside other Ares management affiliated vehicles, enhancing diversification and efficient capital deployment.
Market Positioning: Ares real estate debt platform originated over $9 billion globally in new commitments in 2025, nearly double 2024.
Balance Sheet Flexibility: Maintained moderate leverage and ample liquidity exceeding $100 million, enabling investment in new loans and addressing underperforming loans.
Office Loan Reduction: Reduced office loans by 30% since year-end 2024 to $447 million, with a focus on derisking and restructuring.
Risk Rated Loans: Addressed risk rated 4 and 5 loans, with 5 remaining. The largest loan ($140 million) is a Chicago office loan, and the second largest ($130 million) is a Brooklyn residential condominium loan.
Portfolio Reshaping: Focused on reducing office loans and addressing risk rated 4 and 5 loans to reposition the portfolio for future growth.
Borrowing Capacity: Increased borrowing capacity by $250 million and reduced borrowing costs through facility upsizing and CLO securitization redemption.
Macroeconomic and geopolitical uncertainty: In 2025, macroeconomic and geopolitical uncertainty negatively impacted valuations and transaction activity in the commercial real estate market, creating challenges for the company.
Risk rated 4 and 5 loans: The company has 5 remaining risk rated 4 and 5 loans, with the largest being a $140 million Chicago office loan and a $130 million Brooklyn residential condominium loan. These loans represent significant risks due to their size and potential for loss.
Office property loans: Office loans, which represent 28% of the total loan portfolio, continue to pose risks. The company has reduced exposure but still faces challenges with underperforming office loans, including a downgraded Pennsylvania multifamily property loan.
Nonaccrual loans: The largest risk rated 5 loan, a Chicago office loan, remains on nonaccrual, indicating ongoing financial challenges and uncertainty in recovering the loan's value.
Construction and supply chain risks: The Brooklyn residential condominium loan faced supply chain and tariff risks, although these were mitigated by early procurement of materials. Construction delays or cost overruns could still pose risks.
CECL reserve increase: The CECL reserve increased by $10 million in Q4 2025, with 92% of the reserve related to risk rated 4 and 5 loans. This reflects the potential for credit losses and financial strain.
Uneven earnings trajectory: The company acknowledges that earnings may be uneven depending on the resolution of risk rated 4 and 5 loans, creating uncertainty in financial performance.
Resolution of Risk Rated 4 and 5 Loans: The company is focused on resolving the remaining 5 risk rated 4 and 5 loans in 2026, which is expected to benefit portfolio growth and earnings. The largest loan, a Chicago office loan, is under consideration for potential sale by the borrower, while the second largest, a Brooklyn residential condominium loan, is progressing with construction and sales anticipated to begin in the first half of 2026.
Loan Portfolio Growth and New Investments: In the second half of 2025, the company closed 13 new loan commitments totaling $486 million, with over 50% collateralized by residential and industrial properties. This trend is expected to continue, leveraging co-investment opportunities alongside other Ares management vehicles to enhance diversification and deploy capital efficiently.
Dividend Sustainability and Earnings Growth: The company declared a regular cash dividend of $0.15 per common share for the first quarter of 2026, reflecting confidence in its earnings potential. The execution of the business plan is expected to support earnings growth to sustain the current dividend level.
Capital and Liquidity Position: The company ended 2025 with $110 million in available capital and increased borrowing capacity by $250 million. These actions are expected to support future growth initiatives and enhance financial flexibility.
Regular cash dividend: The board declared a regular cash dividend of $0.15 per common share for the first quarter of 2026. The dividend will be payable on April 15, 2026, to common stockholders of record as of March 31, 2026. At the current stock price on February 5, 2026, the annualized dividend yield on the first quarter dividend is approximately 12%.
The earnings call reveals strong loan portfolio growth, reduction in risk-rated loans, and strategic office loan reduction. Despite some unclear responses in the Q&A, the company demonstrates financial resilience with increased borrowing capacity and focus on resolving high-risk loans. The positive outlook on origination opportunities and strategic capital deployment supports a positive sentiment.
The earnings call reflects mixed signals: while there's a strategic focus on growth and stabilization, with new loan investments and a decrease in net debt-to-equity ratio, the financial performance shows a decline in GAAP net income and a realized loss. The Q&A section highlights concerns about unresolved risk loans and unclear timelines, which may weigh on investor sentiment. Despite some positive aspects like origination activity and market stabilization, the lack of strong guidance and detailed resolutions tempers overall optimism, leading to a neutral sentiment.
The earnings call reflects a mixed sentiment with positive aspects such as debt reduction and strategic opportunities, but also negative points like a reported net loss and unclear future guidance. The Q&A section reveals cautious optimism about future loan originations and market stability, yet uncertainties remain about certain loans and financial impacts. The dividend yield is positive, but the absence of explicit guidance and the realized loss weigh negatively. Overall, the sentiment appears balanced, leading to a neutral prediction for the stock price movement.
The earnings call summary indicates a positive sentiment due to the EPS beat and the share repurchase program. The company is actively managing risks by reducing office loan concentration and maximizing REO investments. Although there are uncertainties in loan resolutions and market conditions, the strategic initiatives and liquidity building efforts position the company well. The Q&A section reveals cautious optimism, with management being selective about new investments. The positive EPS surprise and share buyback plan are likely to result in a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.